Home
Valuation

Work Area: Valuation

SVB’s collapse is a reminder of how far IP finance still has to travel

Like many others, the bank held thousands of patents as security for loan deals, but almost certainly had no idea of their value – or lack of it

The Market Makers of 2022: top 20 revealed

Marconi's Kasim Alfalahi takes the top spot for Avanci's stellar showing in our countdown of the patent market’s most innovative and influential dealmakers and decision takers

Using intangible assets to super charge business valuations

Value can be hidden in the many years of effort, millions of dollars of investment capital and fine-tuned market strategies, which all contribute to driving long-term business success and scaling up a company’s overall worth. It is thus crucial to find a way to reflect this on a company’s balance sheet.

Latest content

Global tax revolution will put corporate IP strategies under far greater scrutiny

New rules on transfer pricing drawn up by the OECD, which could be adopted by authorities in well over 100 countries, are set to have a major impact on how businesses manage their intangible assets

16 February 2023

What college football can teach SPAC sponsors

SPACs can learn much from Coach Saban’s so-called ‘seven-second process’, reshaping it into a unique method to keep investors excited about target businesses and their intangible assets during the dreaded transfer portal period.

15 February 2023

Patent litigation finance booming while insurance market evolving, providers say

Industry practitioners remain optimistic against an unstable financial backdrop

04 January 2023

‘The devil is in the detail' – the Qualcomm take on patent licensing

QTL General Manager John Han speaks to IAM about essentiality checks and valuation during negotiations as well as future pool participation

22 December 2022

Storage Wars: the price of overlooking hidden intangible assets

Companies are failing to conduct proper due diligence assessments that consider intangible assets, which is proving detrimental to their organisation’s true value.

30 November 2022

WiLAN revenues plummet in Q3 on prior year but Micron deal excluded

Strategic review of the licensing business nears a year in motion with no news on potential divestment announced

10 November 2022

Drug royalty agreements can help Big Pharma overcome patent cliffs, says top dealmaker

Behzad Khosrowshahi, CEO of DRI Healthcare Trust, looks at recent deals the firm has done, explains what makes a transaction attractive and how to get one over the line

04 November 2022

IP finance, monetisation and much more take centre stage on Day One of IPBC Asia 2022

A broad range of subjects and talking points - including a plenary address from JPO Commissioner Koichi Hamano - kept the 400+ delegates engaged as the event got underway in Tokyo

01 November 2022

Embracing the future at Singapore’s IP office

In an exclusive interview, IPOS chief executive Rena Lee speaks about digital innovations and her ambitions for Singapore as an IP hub

27 October 2022

Draft US bill proposes federal SEP royalty court with global impact

Proposal seeks to resolve lengthy negotiations but stirs inventor community concerns

18 October 2022

Unlock unlimited access to all IAM content